Kayseri

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Atrial fibrillation

Running trials

• Recruiting

  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  NCT05712200· Phase 3· Anthos Therapeutics, Inc.· Source

  Contact: Anthos Therapeutics a Novartis Company

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting